Related Experiment Video
Updated: Jun 27, 2026
![Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F59557.jpg&w=3840&q=50)
09:50
Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941
Published on: April 28, 2019
Practical synthesis of a p38 MAP kinase inhibitor
Michał Achmatowicz1, Oliver R Thiel, Philip Wheeler
1Chemical Process Research and Development, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, USA. michala@amgen.com
The Journal of Organic Chemistry
|December 18, 2008
Summary
Researchers developed a practical synthesis for a p38 MAP kinase inhibitor using a phthalazine scaffold. This efficient method aids in creating potential treatments for inflammatory diseases.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Pharmacology
Background:
- p38 MAP kinase (mitogen-activated protein kinase) is a key target for inflammatory disease therapies.
- Developing efficient synthetic routes for kinase inhibitors is crucial for drug discovery.
Purpose of the Study:
- To describe a concise and efficient synthesis of a novel p38 MAP kinase inhibitor (compound 1).
- To establish a practical route for synthesizing a key phthalazine building block and a boronic acid intermediate.
Main Methods:
- Phthalazine scaffold construction.
- One-pot synthesis of boronic acid intermediate.
- Multi-step synthesis optimization.
- Reactivity studies of synthetic intermediates.
Main Results:
- A practical synthesis of 1,6-disubstituted phthalazine building block (24) was achieved.
- A one-pot procedure for the formation of boronic acid (27) was developed.
- An optimized synthetic sequence resulted in a practical and efficient synthesis of inhibitor 1.
Conclusions:
- The developed synthetic strategy provides a practical route to a potential p38 MAP kinase inhibitor.
- Understanding intermediate reactivity was key to optimizing the synthetic pathway.
- This work contributes to the development of novel anti-inflammatory agents.

